From October 8th to 10th, the world's largest professional exhibition for the pharmaceutical industry, CPHI Europe (European Pharmaceutical Raw Materials Exhibition), was held in Milan, Italy. Zhu Jiawen, Director of Business Cooperation Department of Jiudian Pharmaceutical, Fan Pengyun, General Manager of Jiudian Hongyang, and Zeng Ling, Director of International Development Department, led the team to participate in the exhibition, winning wide attention with their rich product lines and R&D innovation capabilities.

The exhibition has been held for the 35th time and has received active participation and wide recognition from practitioners in the world's pharmaceutical industry. It has become an annual gathering of practitioners in the pharmaceutical industry around the world. The exhibition area of this exhibition exceeded 160,000 square meters, attracting more than 2,600 companies from all over the world to participate in the exhibition, and the number of visitors reached 43,000 in three days.

The products exhibitedthis time included newly launched APIs such as docusate sodium series, simethicone, oseltamivir phosphate, and aluminum carbonate magnesium, as well as injection & biological excipients such as maltose for injection, sucrose, and sodium octanoate. It is worth mentioning that Jiudian Hongyang passed the on-site inspection of the US FDA with zero defects in 2024, and the E-CTD of docusate sodium API has been successfully submitted to the British authorities and officially started the official European registration. This is a strong reflection of our company's overseas expansion capabilities and the gradual completion of overseas commercialization layout.

During the exhibition, our team had in-depth exchanges with customers from all over the world. Visitors expressed their strong interest in our products and gave positive comments on our year-on-year performance growth. Since its listing, Jiudian has been committed to promoting the globalization of high-quality products with domestic and foreign partners. Through the two-way exchanges of this exhibition, it has demonstrated its comprehensive strength in R&D, production and sales, which not only consolidated the cooperative relationship with existing customers, but also expanded new partners. Together with partners, it witnessed the healthy development of Jiudian and laid a solid foundation for future development.

This time, the Jiudian team received more than 100 exhibitors from all over the world, including well-known domestic and foreign industry pioneer pharmaceutical companies, such as Bayer, Swiss Cap, Kirsch, Almirall, Normon, etc. Jiudian Business Cooperation Department focused on the export of preparations and actively conducts in-depth exchanges with global trading partners. It aims to strive to expand the international market for preparations through this event, strengthen cooperation with global traders, and actively promote Jiudian's preparations to all parts of the world.

Through this exhibition, Jiudian not only showcased the company's latest achievements, but also gained a lot of valuable market information and customer feedback. By communicating and learning with global peers, Jiudian's international influence was further enhanced, and more international cooperation projects were promoted. In the future, the company will continue to uphold the concept of "Jiudian's transformation from Chinese to Western medicine, Diano Health", continuously improve product quality and service levels, actively participate in various international exhibitions, continuously expand the international market, and contribute more to the development of the global pharmaceutical industry.